Trial intelligence / Profile preview

Evaluation of the effect of letrozole on symptomatic uterine leiomyomas

IRCT201102015444N2Phase 2Completed

Sponsor
Kashan University of Medical Sciences (Research Division)
Start
Aug 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of letrozole in Fibromyoma (LM), sponsored by Kashan University of Medical Sciences (Research Division). Started Aug 2009; status: completed.

02

Drugs

letrozole
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on IRCT201102015444N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201102015444N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call